NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,034 | -$6,684 | -$2,677 | – |
| Dep. & Amort. | $1 | $1 | $4 | – |
| Deferred Tax | -$19 | -$1,657 | $972 | – |
| Stock-Based Comp. | $166 | $2,500 | $790 | – |
| Change in WC | $529 | $112 | -$144 | – |
| Other Non-Cash | $277 | -$92 | $202 | – |
| Operating Cash Flow | -$1,081 | -$5,821 | -$853 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | $0 | – |
| Net Acquisitions | $0 | $0 | $0 | – |
| Inv. Purchases | $0 | -$58 | $0 | – |
| Inv. Sales/Matur. | $72 | $450 | $0 | – |
| Other Inv. Act. | $0 | $0 | $0 | – |
| Investing Cash Flow | $72 | $389 | $0 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | – |
| Stock Issued | $0 | $4,600 | $804 | – |
| Stock Repurch. | $0 | $0 | $0 | – |
| Dividends Paid | $0 | $0 | $0 | – |
| Other Fin. Act. | $271 | $6,204 | $747 | – |
| Financing Cash Flow | $271 | $6,204 | $747 | – |
| Forex Effect | $0 | $0 | $0 | – |
| Net Chg. in Cash | -$738 | $772 | -$107 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $774 | $1 | $108 | – |
| End Cash | $36 | $774 | $1 | – |
| Free Cash Flow | -$1,081 | -$5,824 | -$853 | – |